Treatment of Recurrent and Metastatic Esophageal Cancer

Pavarana, M.; Sava, Teodoro

doi:10.1007/978-88-470-2330-7_17

Cited by 1 publication

(1 citation statement)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ESCC is the result of multiple genetic and environmental factors that jointly participate in dysregulating a number of oncogenes and tumor suppressor genes [ 15 ]. Two traditional chemotherapeutics, paclitaxel (Taxol) and cisplatin (cis-diamminedichloroplatinum II), have been successfully used in ESCC patients [ 16 ]. Paclitaxel stabilizes microtubules and reduces their dynamicity (thereby promoting mitotic arrest and apoptosis) and has demonstrated strong results in the treatment of several early stage tumors, including esophageal cancer, lung cancer, cervical cancer, ovarian cancer, and prostate cancer [ 17 ].…”

Section: Discussionmentioning

confidence: 99%

Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells

Huang

Chen

Wang

et al. 2015

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Esophageal carcinoma is a major public health problem worldwide and one of the most aggressively malignant neoplasms. Although considerable diagnostic and therapeutic progress has been made in recent years, the prognosis of EC patients still remains dismal due to high rates of recurrence/metastasis and invasion. Previous studies have demonstrated that Epithelial mesenchymal transition (EMT) is proposed as a critical mechanism for the acquisition of malignant phenotypes by epithelial cells. Several lines of evidence have shown that Cripto-1 plays an important oncogenic role during tumorigenesis by promoting EMT. The aim of our study was to evaluate the significance of Cripto-1 which plays a role in EMT and its metastasis in esophageal carcinoma. Data of this study suggest that Cripto-1 overexpression is connected with the tumorigenesis and progression of esophageal carcinoma; shRNA might be feasible for the inhibition of the invasion and metastasis of esophageal carcinoma.

show abstract

Section: Discussionmentioning

confidence: 99%